Medical Device Network:
HDPCR is an advanced method for multiplexing biomarkers in a single, rapid assay across multiple sample types. ChromaCode has entered a strategic partnership with Protean BioDiagnostic for the launch of a non-small cell lung cancer (NSCLC) assay in the US.
To be available through an early access programme, the assay leverages ChromaCode’s High Definition PCR (HDPCR) multiplexing technology.
